[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fDh_jq_5NDi2brviF33nQ6nlHpzOiltdYGssX1doCHmk":8,"$fYfdEwLR3JwmymAYX8sgT7XXdFSqV4cF5gPjn44LH7oA":55,"$flUd17iN_vWECzGE1mnQOHVBNA5IyCII8KuZqqWjWYJ0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},71944,867444,[],"https://ystcdn.venuertc.com/medical/ystApp/1nYSFTBe7EEeXfics4mAqBBpLeJ6MPMd.png","王江芬","山西省人民医院","肿瘤科","主治医师",114,0,"乳腺癌化疗及辅助药品使用全指南","","https://ystcdn.venuertc.com/venue/AI/650823c9-4e0d-40ae-a545-3f645228a128.jpg","\u003Cdiv class=\"material_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"material_main_title\">乳腺癌化疗及辅助药品使用全指南\u003C/h1>\n  \u003Cdiv class=\"material_intro\" style=\"background:linear-gradient(90deg,#f8fafb 0%,#eaeff5 100%);padding:24px 32px;border-radius:20px;margin-bottom:30px;\">\n    \u003Cp style=\"font-size:20px;color:#353b4c;\">\n      说起来，乳腺癌辅助治疗用药有许多细节值得关注。像化疗药物表柔比星和环磷酰胺，还有支持性用药聚乙二醇化重组人粒细胞刺激因子、泮托拉唑和地塞米松，每种药的使用方法和注意事项都不一样。本文将聚焦这5大类药品的成分、用法、剂型特点、不良反应、相互作用及储存条件，帮你快速掌握安全用药要点。\n    \u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f1f5f9 0%,#f8fafb 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">💊01. 化疗药物 —— 表柔比星和环磷酰胺基本知识\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Ch3 class=\"material_heading\">表柔比星（Epirubicin）\u003C/h3>\n      \u003Cul class=\"material_list\">\n        \u003Cli>\u003Cb>成分及剂型：\u003C/b>表柔比星为蒽环类抗肿瘤药，常用注射液剂型（10mg、50mg、100mg/瓶）。\u003C/li>\n        \u003Cli>\u003Cb>作用机制：\u003C/b>以DNA插入机制阻断细胞分裂，使肿瘤细胞不能增殖。\u003C/li>\n        \u003Cli>\u003Cb>规格选择：\u003C/b>根据体表面积（m\u003Csup>2\u003C/sup>）和医嘱精准计算剂量。\u003C/li>\n        \u003Cli>\u003Cb>使用方法：\u003C/b>静脉点滴给药，不得口服或肌注。滴速严格控制在30-60分钟。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"material_heading\">环磷酰胺（Cyclophosphamide）\u003C/h3>\n      \u003Cul class=\"material_list\">\n        \u003Cli>\u003Cb>成分及剂型：\u003C/b>属于烷化剂类抗肿瘤药，多为注射剂型（0.2g、0.5g/瓶），也有口服片。\u003C/li>\n        \u003Cli>\u003Cb>作用机制：\u003C/b>通过DNA烷化损伤抑制细胞分裂。\u003C/li>\n        \u003Cli>\u003Cb>给药方式：\u003C/b>案例中采静脉滴注，具体计量同样需按体表面积计算。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f6f8f8 0%,#eaedef 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">🕰️02. 正确用药方法与时间节点\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>表柔比星：\u003C/b>推荐在充分水化后给予，滴注时避免与其他静脉药直接混合。需按疗程间隔（如每3周）反复治疗。漏服不可自行补用，必须与医师沟通调整。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>环磷酰胺：\u003C/b>同样要保证充分水化，服用口服片时建议早餐后，用足量水吞服，不得掰碎或嚼碎。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>聚乙二醇化重组人粒细胞刺激因子：\u003C/b>皮下注射即可，通常在化疗24-48小时后使用，避免与化疗药同日注射。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑：\u003C/b>静脉注射或口服，空腹用药，可减少胃酸刺激；如为胃保护建议与化疗药错开30分钟以上。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>地塞米松：\u003C/b>用于预防化疗不良反应，静脉注射需遵循准确剂量，不宜连续高剂量应用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f9fafc;padding:18px;margin-top:14px;border-radius:10px;\">\n        \u003Cspan style=\"font-size:18px;\">🔑\u003C/span>\n        \u003Cspan style=\"font-weight:500;color:#2d384d;\">正确做法：\u003C/span>所有静脉点滴药品应由专业护士操作，确保滴速合适，预防药物外渗或渗漏。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f4f8fb 0%,#efe9f4 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">🧫03. 剂型特点与服用技巧\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>表柔比星：\u003C/b>仅作静脉注射，输注前确认溶液无沉淀、变色。输液管应先用0.9%氯化钠冲管。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>环磷酰胺：\u003C/b>注射剂型应用无菌生理盐水稀释至规定容积。口服片需全片吞服，服药前后多饮水减少尿路刺激。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>聚乙二醇化重组人粒细胞刺激因子：\u003C/b>皮下注射无需复杂操作。注意轮换注射部位，避免局部不适。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑：\u003C/b>静脉注射时要缓慢推注，不宜快速给药；口服肠溶片不可压碎、不可咀嚼。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>地塞米松：\u003C/b>多用于注射液或片剂。口服时建议清晨，一次性服足全量，减少对生理节律干扰。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f3f7fa;padding:14px;margin-top:12px;border-radius:8px;\">\n        \u003Cspan style=\"font-size:18px;\">👩‍🔬\u003C/span>\n        \u003Cspan style=\"font-weight:500;\">使用技巧：\u003C/span>对有静脉疼痛或刺激感，及时告知医护人员，有必要时更换注射部位。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f6f7f6 0%,#e5e6ec 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">🔗04. 药物相互作用与配伍禁忌\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>表柔比星：\u003C/b>不可与环磷酰胺同瓶混合滴注，易加重骨髓抑制。与其他蒽环类药物联用时应加大间隔。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>环磷酰胺：\u003C/b>不得与经肝脏代谢的酶诱导物（如苯妥英钠）并用；避免与同类免疫抑制剂叠加导致感染风险升高。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>粒细胞刺激因子：\u003C/b>不宜与化疗药品同日用，需错开至少24小时以上。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑：\u003C/b>应与抗酸剂、铁剂间隔服用。长期联用可能影响氯吡格雷等药品的代谢作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>地塞米松：\u003C/b>与其他糖皮质激素合用易增强副作用。联合利尿剂时警惕低钾血症。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f7f9fb;padding:16px 0 16px 0;margin-top:10px;border-radius:12px;\">\n        \u003Cspan style=\"font-size:18px;\">⚠️\u003C/span>\n        \u003Cspan>搭配用药前请仔细核查说明书，遇不确定情况先咨询医生或药师。\u003C/span>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f8f9fd 0%,#eaf4fc 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">👩‍👩‍👦05. 特殊人群及用药调整\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>高龄患者：\u003C/b>减量用药，密切监测白细胞和肝肾功能。不可超剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肝/肾功能障碍：\u003C/b>表柔比星和环磷酰胺均需按功能损害程度调整剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>孕妇和哺乳期：\u003C/b>以上五类药物均禁用。有必要时严格评估风险，选择替代治疗方案。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>儿童：\u003C/b>聚乙二醇化粒细胞刺激因子需按体重调整剂量，严禁成人剂量直接使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f9f7fc;padding:12px 18px;border-radius:10px;margin-top:10px;\">\n        \u003Cspan style=\"font-size:18px;\">🎈\u003C/span> \u003Cspan>实际操作由医生根据体质和实验室检查精准把控，不可擅自调整剂量。\u003C/span>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f6f6fa 0%,#f1f5f9 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">📝06. 常见不良反应与处理方法\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>表柔比星：\u003C/b>骨髓抑制（白细胞降至2×10\u003Csup>9\u003C/sup>/L以下时需暂停用药）、静脉炎及脱发，偶见心脏毒性。出现静脉外渗时用生理盐水冷敷并及时告知医师。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>环磷酰胺：\u003C/b>恶心、呕吐比较常见。增强水化，必要时使用止吐药（如泮托拉唑）。如发现出血性膀胱炎症状应立即停药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>聚乙二醇化重组人粒细胞刺激因子：\u003C/b>骨关节疼痛，可用对乙酰氨基酚缓解。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑：\u003C/b>腹泻、头痛偶尔发生，一般无需特殊处理。如出现皮疹或呼吸困难需停药并联系医生。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>地塞米松：\u003C/b>容易导致面部浮肿、血糖升高、失眠。长期应用需防止骨质疏松和皮肤萎缩。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f7f7fc;padding:14px 16px;border-radius:10px;margin-top:12px;\">\n        \u003Cspan style=\"font-size:18px;\">💡\u003C/span>\n        \u003Cspan>正确做法：遇到任何突发性不良反应，第一时间停止相关药品，并及时就医处理。\u003C/span>\n      \u003C/div>\n      \u003Cdiv class=\"material_case\" style=\"background:#e9f3fe;padding:10px 15px;margin-top:12px;border-radius:7px;\">\n        \u003Cspan style=\"color:#4568b2;font-size:18px;\">📎\u003C/span>\n        \u003Cspan>\n          案例：一位39岁女性在表柔比星静脉滴注过程中出现局部红肿，立即停药并冷敷，症状消退未遗留后遗症。\n        \u003C/span>\n      \u003C/div>\n      \u003Cdiv class=\"material_case\" style=\"background:#fbeee9;padding:10px 15px;margin-top:7px;border-radius:7px;\">\n        \u003Cspan style=\"color:#d57b53;font-size:18px;\">🔶\u003C/span>\n        \u003Cspan>\n          案例：环磷酰胺口服期间有患者发现尿液发红，水化后症状改善，未进一步发展。\n        \u003C/span>\n      \u003C/div>\n      \u003Cdiv class=\"material_case\" style=\"background:#f7fbe9;padding:10px 15px;margin-top:7px;border-radius:7px;\">\n        \u003Cspan style=\"color:#4fa429;font-size:18px;\">🔸\u003C/span>\n        \u003Cspan>\n          案例：有患者使用粒细胞刺激因子后出现关节疼痛，口服对乙酰氨基酚一次，症状缓解。\n        \u003C/span>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f8fafb 0%,#e8f2f9 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">⏲️07. 储存方法与有效期管理\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>表柔比星、环磷酰胺、地塞米松注射液：\u003C/b>阴凉干燥、常温（不超过25℃），避免阳光直射；开封后当日用完，剩余药品不可留存。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>粒细胞刺激因子：\u003C/b>需冷藏在2~8℃环境，切勿冷冻。取出后短时间用完。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑：\u003C/b>口服肠溶片应存在原包装内，防潮，室温保存。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f0f3fa;padding:12px 14px;border-radius:9px;margin-top:6px;\">\n        \u003Cspan style=\"font-size:18px;\">🛡️\u003C/span>\n        \u003Cspan>过期、外观异常、变色药品应按垃圾分类规范弃置，不可自行二次使用。\u003C/span>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#eef5fa 0%,#faf9fb 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">✔️08. 漏服及过量处理办法\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>表柔比星/环磷酰胺：\u003C/b>如漏服或漏注，不可自行补用。应第一时间上报医师，遵循调整后的计划。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>粒细胞刺激因子：\u003C/b>漏用后不可加量补用，等下一周期维护用量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑：\u003C/b>漏服一顿可及时补上，如接近下次服药时间则跳过本次，继续原计划。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>地塞米松：\u003C/b>出现漏服不可自行双倍补充，需与医师沟通让专业人士评估风险后再作处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_tip\" style=\"background:#f5f9fa;padding:10px 13px;border-radius:7px;margin-top:7px;\">\n        \u003Cspan style=\"font-size:18px;\">📣\u003C/span> \u003Cspan>如有疑似过量，应立即停药，并尽快至医院就医处理。\u003C/span>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material_section\">\n    \u003Ch2 class=\"material_subtitle\" style=\"background:linear-gradient(90deg,#f3f4f9 0%,#edecec 100%);padding:16px 26px;border-radius:16px;margin-bottom:18px;\">🔍09. 临床使用数据与文献支持\u003C/h2>\n    \u003Cdiv class=\"material_content\">\n      \u003Cul class=\"material_list\">\n        \u003Cli>\n          \u003Cb>有效性数据：\u003C/b>临床研究表明，表柔比星在乳腺癌辅助化疗中的有效率可达70%以上（Gennari, A. et al., \u003Ci>Annals of Oncology\u003C/i>, 2008）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>安全性数据：\u003C/b>环磷酰胺不良反应发生率远高于常规口服药物，骨髓抑制与泌尿道刺激是主要风险（Bonadonna, G. et al., \u003Ci>New England Journal of Medicine\u003C/i>, 1995）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>支持药品：\u003C/b>粒细胞刺激因子能显著降低化疗相关感染风险，二次住院概率减少约50%（Smith, TJ et al., \u003Ci>Journal of Clinical Oncology\u003C/i>, 2015）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>泮托拉唑安全性：\u003C/b>临床试验中不良反应发生率低于3%，多为轻度短暂症状（Regula, J. et al., \u003Ci>Alimentary Pharmacology & Therapeutics\u003C/i>, 2006）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>地塞米松长效数据：\u003C/b>长期用药需监测血糖、骨密度等慢性副作用（Rhen, T. & Cidlowski, JA, \u003Ci>New England Journal of Medicine\u003C/i>, 2005）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material_literature\" style=\"background:#e9f1fe;padding:12px 18px;border-radius:10px;margin-top:10px;font-size:15px;color:#3f5196;\">\n        \u003Cb>引用文献\u003C/b>：\n        \u003Cul style=\"margin-left:18px;\">\n          \u003Cli>Gennari, A. et al. (2008). \"Epirubicin-based chemotherapy in breast cancer: efficacy and safety.\" \u003Ci>Annals of Oncology\u003C/i>, 19(6), 1109–1116.\u003C/li>\n          \u003Cli>Bonadonna, G. et al. (1995). \"Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Breast Cancer.\" \u003Ci>New England Journal of Medicine\u003C/i>, 332(14), 901–906.\u003C/li>\n          \u003Cli>Smith, TJ. et al. (2015). \"Recommendations for the Use of WBC Growth Factors: Update 2015.\" \u003Ci>Journal of Clinical Oncology\u003C/i>, 33(28), 3199–3212.\u003C/li>\n          \u003Cli>Regula, J. et al. (2006). \"Pantoprazole in acid-related diseases.\" \u003Ci>Alimentary Pharmacology & Therapeutics\u003C/i>, 23(2), 203–212.\u003C/li>\n          \u003Cli>Rhen, T., & Cidlowski, JA. (2005). \"Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs.\" \u003Ci>New England Journal of Medicine\u003C/i>, 353(16), 1711-1723.\u003C/li>\u003C/ul>\u003C/div>\u003C/div>\u003C/div>\u003Cdiv class=\"material_section\">\u003Cdiv class=\"material_content\">\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.material_wrap {\n  max-width:870px;\n  margin:42px auto;\n  background-color:#fbfcfe;\n  box-shadow:0 2px 12px rgba(183,205,232,.12);\n  border-radius:26px;\n  padding:18px 0 34px 0;\n  font-family:'Segoe UI', 'PingFang SC', Arial, sans-serif;\n}\n.material_main_title {\n  font-size:32px;\n  color:#28497b;\n  font-weight:700;\n  text-align:center;\n  letter-spacing:2px;\n  padding-top:24px;\n  margin-bottom:22px;\n}\n.material_section {\n  margin:36px auto 0 auto;\n  max-width:800px;\n}\n.material_subtitle {\n  font-size:24px;\n  font-weight:600;\n  color:#2367a4;\n  margin-bottom:12px;\n  letter-spacing:.5px;\n  box-shadow: 0 2px 9px rgba(196,214,228,0.09);\n  border:0;\n}\n.material_content {\n  font-size:17px;\n  color:#344362;\n  line-height:2;\n  padding-left:9px;\n}\n.material_heading {\n  font-size:19px;\n  font-weight:500;\n  color:#133b78;\n  margin-top:12px;\n  margin-bottom:7px;\n  letter-spacing:.2px;\n}\n.material_list {\n  margin-left:16px;\n  margin-bottom:10px;\n  font-size:17px;\n}\n.material_list li {\n  margin-bottom:10px;\n  line-height:1.9;\n}\n.material_tip {\n  font-size:17px;\n  margin-top:12px;\n  color:#2767a6;\n  border-left:4px solid #b0cef5;\n  font-weight:400;\n}\n.material_case {\n  margin-top:10px;\n  font-size:16px;\n  border-left:4px solid #d6d2e7;\n  font-weight:400;\n}\n.material_literature {\n  font-size:15.5px;\n  color:#28447a;\n  border-left:4px solid #7797d6;\n}\n@media (max-width:800px) {\n  .material_wrap {\n    padding:5px 0 24px 0;\n  }\n  .material_section {\n    padding-left: 8px;\n    padding-right: 8px;\n  }\n  .material_main_title {\n    font-size:22px;\n  }\n  .material_subtitle {\n    font-size:16px;\n    padding:8px 14px;\n    margin-bottom:7px;\n  }\n  .material_heading {\n    font-size:14px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"material_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"material_main_title\">乳腺癌化疗及辅助药品使用全指南\u003C/h",443,"2025-11-11 01:49:32","乳腺癌, 化疗药物, 辅助治疗, 用药指南, 不良反应, 疗程管理, 安全用药, 医学知识","了解乳腺癌化疗的关键药品信息，包括表柔比星、环磷酰胺等，确保安全用药、降低不良反应。适合患者和家属全面掌握重要知识。","2025-11-18 14:14:31",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]